Skip to content

What is olanzapine?

2 min read

An estimated 4.4% of U.S. adults experience bipolar disorder at some time in their lives. For conditions like this and schizophrenia, a key question for treatment is, what is olanzapine? It's a second-generation antipsychotic that helps manage symptoms.

Quick Summary

Olanzapine is an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder. It works by rebalancing dopamine and serotonin to improve thinking, mood, and behavior.

Key Points

  • What it is: Olanzapine is a second-generation antipsychotic for schizophrenia and bipolar disorder.

  • How it works: Thought to balance dopamine and serotonin to regulate mood, thoughts, and behavior.

  • Approved Uses: Includes schizophrenia, bipolar I disorder episodes, bipolar depression (with fluoxetine), and treatment-resistant depression (with fluoxetine).

  • Black Box Warning: Increased death risk in elderly dementia-related psychosis patients; not approved for this use.

  • Major Side Effects: High risk of metabolic changes (weight gain, high blood sugar, high cholesterol). Drowsiness is common.

  • Drug Interactions: Can interact with CNS depressants, blood pressure medications, carbamazepine, fluvoxamine, and smoking.

  • Administration: Usually taken daily; available as tablets, dissolving tablets, and injections.

In This Article

What is Olanzapine?

Olanzapine is a prescription medication categorized as a second-generation (atypical) antipsychotic, approved by the FDA in 1996. It is available under brand names such as Zyprexa. The medication works in the brain to help manage symptoms of certain mental health conditions by affecting neurotransmitters like dopamine and serotonin, which can improve thinking, mood, and behavior. Olanzapine comes in various forms, including tablets and injections.

Mechanism of Action

Olanzapine's effects are thought to stem from its action as an antagonist at dopamine and serotonin receptors in the brain, including D2 and 5HT2A receptors. This receptor blockade may help reduce both the positive and negative symptoms of schizophrenia. Olanzapine also interacts with other receptors, including muscarinic, histamine H1, and adrenergic α1, which may contribute to its effects.

FDA-Approved and Off-Label Uses

Olanzapine is FDA-approved for conditions including schizophrenia, bipolar I disorder (acute manic/mixed episodes, maintenance, combination with lithium or valproate), bipolar depression (with fluoxetine), treatment-resistant depression (with fluoxetine), and acute agitation (intramuscular injection for schizophrenia and bipolar I mania) in adults and adolescents. Off-label uses may include preventing chemotherapy-induced nausea and vomiting and managing symptoms in palliative care.

Administration

Olanzapine is typically taken once daily and can be taken with or without food. It is available as tablets, orally disintegrating tablets, and injections (short-acting for acute agitation, long-acting for schizophrenia maintenance).

Side Effects and Warnings

Common side effects include drowsiness, weight gain, dizziness, dry mouth, and constipation.

Serious Side Effects and Boxed Warning

A black box warning exists regarding an increased death risk in elderly patients with dementia-related psychosis; olanzapine is not approved for this use. Other serious risks include metabolic changes (weight gain, high blood sugar, increased cholesterol), tardive dyskinesia, neuroleptic malignant syndrome, and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).

Olanzapine Compared to Other Antipsychotics

Feature Olanzapine Risperidone Aripiprazole
Efficacy Potentially slightly more effective for schizophrenia. May be more effective than aripiprazole in some first-episode schizophrenia cases. Potentially less effective than olanzapine.
Weight Gain High risk. Moderate risk. Low risk.
Sedation High risk. Moderate risk. Low risk.
Movement Disorders (EPS) Lower risk compared to risperidone and aripiprazole. Higher risk of elevated prolactin. Can cause akathisia.

Drug Interactions

Olanzapine can interact with other substances, including CNS depressants (e.g., alcohol), blood pressure medications, carbamazepine, fluvoxamine, and its levels can be affected by smoking. Patients should discuss all medications and supplements with their doctor.

Conclusion

Olanzapine is used for severe mental health conditions like schizophrenia and bipolar disorder. While effective in balancing brain chemicals, it carries risks, particularly metabolic side effects. Comparing it with other antipsychotics and deciding on its use requires careful consultation with a healthcare provider to determine the best treatment for an individual's needs.


For more information, you can visit the {Link: NAMI https://www.nami.org/about-mental-illness/treatments/mental-health-medications/types-of-medication/olanzapine-zyprexa/}.

Frequently Asked Questions

Olanzapine is primarily used to treat schizophrenia in adults and adolescents (13+), and to treat various episodes of bipolar I disorder, including acute mania and maintenance treatment.

Yes, weight gain is a very common side effect of olanzapine. Patients and their doctors should monitor weight regularly during treatment.

No, olanzapine is not a controlled substance. It does not have a high risk for misuse or addiction.

While some effects may be noticed sooner, it can take several weeks for olanzapine to show its full effect. The half-life is about 21 to 54 hours.

Olanzapine has a black box warning about an increased risk of death in elderly patients with dementia-related psychosis and is not approved for this use.

Avoiding alcohol while taking olanzapine is recommended as it can increase side effects like drowsiness.

If a dose is missed, take it when remembered. If it is close to the next dose, skip the missed one. Do not double doses.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.